West Pharmaceutical Services Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名28/208位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价345.24。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
West Pharmaceutical Services Inc评分
相关信息
行业排名
28 / 208
全市场排名
97 / 4582
所属行业
医疗设备与耗材
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
18
位分析师
买入
评级
345.245
目标均价
+28.31%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
West Pharmaceutical Services Inc亮点
亮点风险
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
公司代码WST
公司West Pharmaceutical Services Inc
CEOGreen (Eric Mark)
网址https://www.westpharma.com/
常见问题
West Pharmaceutical Services Inc(WST)的当前股价是多少?
West Pharmaceutical Services Inc(WST)的当前股价是 272.440。
West Pharmaceutical Services Inc的股票代码是什么?
West Pharmaceutical Services Inc的股票代码是WST。
West Pharmaceutical Services Inc股票的52周最高点是多少?
West Pharmaceutical Services Inc股票的52周最高点是348.900。
West Pharmaceutical Services Inc股票的52周最低点是多少?
West Pharmaceutical Services Inc股票的52周最低点是187.430。